Drug Shortage Report for TEVA-CLOBETASOL
Report ID | 141457 |
Drug Identification Number | 01910272 |
Brand name | TEVA-CLOBETASOL |
Common or Proper name | CLOBETASOL 0.05% CREAM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CLOBETASOL PROPIONATE |
Strength(s) | 0.05% |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 15g & 50g |
ATC code | D07AD |
ATC description | CORTICOSTEROIDS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-06-23 |
Estimated end date | 2022-01-31 |
Actual end date | 2022-02-04 |
Shortage status | Resolved |
Updated date | 2022-02-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2022-02-05 | English | Compare |